ethyl pyruvate has been researched along with B16 Melanoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sakamoto, K; Zhou, S | 1 |
Curtis, P; DuHadaway, JB; Jaller, D; Metz, R; Muller, AJ; Prendergast, GC | 1 |
2 other study(ies) available for ethyl pyruvate and B16 Melanoma
Article | Year |
---|---|
Pyruvic acid/ethyl pyruvate inhibits melanogenesis in B16F10 melanoma cells through PI3K/AKT, GSK3β, and ROS-ERK signaling pathways.
Topics: Animals; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3 beta; MAP Kinase Signaling System; Melanins; Melanoma, Experimental; Mice; Microphthalmia-Associated Transcription Factor; Models, Biological; Monophenol Monooxygenase; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Pyruvates; Pyruvic Acid; Reactive Oxygen Species | 2019 |
Immunotherapeutic suppression of indoleamine 2,3-dioxygenase and tumor growth with ethyl pyruvate.
Topics: Animals; Anti-Inflammatory Agents; Cell Growth Processes; Enzyme Inhibitors; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Nude; Pyruvates; RNA, Messenger; T-Lymphocytes; U937 Cells | 2010 |